Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Scott M. Schuetze

ResearcherPublications, citations & collaboration network

Scott M. Schuetze is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 277 works, 20,625 citations, an h-index of 60 and an i10-index of 133.

277
Works
20,625
Citations
60
h-index
133
i10-index

How has Scott M. Schuetze's publication output changed over time?

ScholarIQpublication output · 2007–2022

Output grew0% over the shown period — from 1 works in 2007 to 1 in 2022.

1
2
1
2
1
1
2
1
1
200720092010201320142015201720182022

What are the most-cited papers on Scott M. Schuetze?

ScholarIQmost cited works
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
The Lancet Oncology. 20171,446 CitationsOPEN ACCESS
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
George D. Demetri, Margaret von Mehren, Cristina R. Antonescu, Ronald P. DeMatteo, Kristen N. Ganjoo, Robert G. Maki, Peter W. T. Pisters, Chandrajit P. Raut, Richard F. Riedel, Scott M. Schuetze, Hema Sundar, Jonathan C. Trent, Jeffrey D. Wayne
Journal of the National Comprehensive Cancer Network. 20101,223 Citations
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M. Kane, Mark Agulnik, Marilyn M. Bui, Janai R. Carr, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo González, Ashley M. Holder, Jade Homsi, Vicki L. Keedy, Ciara M. Kelly, Edward Kim, David A. Liebner, Martin D. McCarter, Sean V. McGarry, Nathan W. Mesko, Christian F. Meyer, Alberto S. Pappo, Amanda Parkes, Ivy A. Petersen, Seth M. Pollack, Matthew M. Poppe, Richard F. Riedel, Scott M. Schuetze, Jacob E. Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa N. Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman
Journal of the National Comprehensive Cancer Network. 20221,173 CitationsOPEN ACCESS
Integrative clinical genomics of metastatic cancer
Dan R. Robinson, Yi-Mi Wu, Robert J. Lonigro, Pankaj Vats, Erin F. Cobain, Jessica N. Everett, Xuhong Cao, Erica Rabban, Chandan Kumar‐Sinha, Victoria M. Raymond, Scott M. Schuetze, Ajjai Alva, Javed Siddiqui, Rashmi Chugh, Francis P. Worden, Mark M. Zalupski, Jeffrey W. Innis, Rajen Mody, Scott A. Tomlins, David R. Lucas, Laurence H. Baker, Nithya Ramnath, Ann F. Schott, Daniel F. Hayes, Joseph Vijai, Kenneth Offit, Elena M. Stoffel, J. Scott Roberts, David C. Smith, Lakshmi P. Kunju, Moshe Talpaz, Marcin Cieślik, Arul M. Chinnaiyan
Nature. 2017938 CitationsOPEN ACCESS
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D. Demetri, Margaret von Mehren, Robin L. Jones, Martee L. Hensley, Scott M. Schuetze, Arthur P. Staddon, Mohammed Milhem, A. Elias, Kristen N. Ganjoo, Hussein A. Tawbi, Brian Andrew Van Tine, Alexander I. Spira, Andrew Dean, Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, Trilok Parekh, Robert G. Maki, Shreyaskumar Patel
Journal of Clinical Oncology. 2015839 CitationsOPEN ACCESS

Related on ScholarIQ

University of Michigan
Institution
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Paper
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
Paper
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Paper
Integrative clinical genomics of metastatic cancer
Paper
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
Paper
470M+ articles · free account